Cocrystal Pharma (COCP) Non-Current Assets (2010 - 2026)

Cocrystal Pharma (COCP) has 16 years of Non-Current Assets data on file, last reported at $1.5 million in Q1 2026.

• For the quarter ending Q1 2026, Non-Current Assets fell 18.88% year-over-year to $1.5 million; the trailing twelve-month figure through Mar 2026 stood at $6.5 million (down 14.87% YoY), and the FY2025 full-year result was $1.6 million, down 15.88% from the prior year.
• Non-Current Assets retreated to $1.5 million in Q1 2026, from $1.6 million in the prior quarter.
• In the past five years, Non-Current Assets ranged from a high of $20.0 million in Q1 2022 to a low of $409000.0 in Q3 2023.
• A 5-year average of $2.5 million and a median of $1.7 million in 2025 frame the typical range for Non-Current Assets.
• Across the five-year window, Non-Current Assets slumped 96.97% in 2023 and surged 383.37% in 2024, its largest moves.
• Tracing COCP's Non-Current Assets over 5 years: stood at $662000.0 in 2022, then soared by 227.49% to $2.2 million in 2023, then slipped by 13.47% to $1.9 million in 2024, then slipped by 15.88% to $1.6 million in 2025, then dropped by 5.77% to $1.5 million in 2026.
• Business Quant data shows COCP's Non-Current Assets at $1.5 million in Q1 2026, $1.6 million in Q4 2025, and $1.7 million in Q3 2025.